About company
Symphogen is the leader in developing recombinant polyclonal antibodies (rpAb), a new class of biopharmaceuticals for the treatment or prophylaxis of serious human diseases.
- DK
- info@symphogen.com
- Unknown
- symphogen.com
- Not verified company
